Sierra Oncology, Inc. - FORM S-1 - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - June 12, 2015

Attached files

file filename
S-1 - FORM S-1 - Sierra Oncology, Inc.d900346ds1.htm
EX-3.1 - FIFTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION, AS AMENDED - Sierra Oncology, Inc.d900346dex31.htm
EX-10.11 - EXCLUSIVE LICENSE AMENDMENT - Sierra Oncology, Inc.d900346dex1011.htm
EX-4.2 - THIRD AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT - Sierra Oncology, Inc.d900346dex42.htm
EX-3.3 - AMENDED AND RESTATED BYLAWS - Sierra Oncology, Inc.d900346dex33.htm
EX-10.2 - 2008 STOCK PLAN, AS AMENDED - Sierra Oncology, Inc.d900346dex102.htm
EX-10.9 - LEASE, MICHIGAN LIFE SCIENCES - Sierra Oncology, Inc.d900346dex109.htm
EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - Sierra Oncology, Inc.d900346dex211.htm
EX-10.8 - SEPARATION AND RELEASE AGREEMENT - Sierra Oncology, Inc.d900346dex108.htm
EX-10.13 - LICENSE PAYMENT AGREEMENT - Sierra Oncology, Inc.d900346dex1013.htm
EX-10.10 - LEASE, THOMPSON CREEK METALS COMPANY - Sierra Oncology, Inc.d900346dex1010.htm
EX-10.1 - FORM OF INDEMNIFICATION AGREEMENT - Sierra Oncology, Inc.d900346dex101.htm
EX-3.4 - FORM OF RESTATED BYLAWS - Sierra Oncology, Inc.d900346dex34.htm
EX-3.2 - FORM OF RESTATED CERTIFICATE OF INCORPORATION - Sierra Oncology, Inc.d900346dex32.htm
EX-10.12 - SECOND LICENSE AMENDMENT AND CONSENT TO TERMINATION - Sierra Oncology, Inc.d900346dex1012.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the use in this Registration Statement on Form S-1 of our report dated April 8, 2015 relating to the consolidated financial statements of ProNAi Therapeutics, Inc., appearing in the Prospectus, which is part of this Registration Statement.

We also consent to the reference to us under the heading “Experts” in such Prospectus.

/s/ Deloitte & Touche LLP

Detroit, Michigan

June 12, 2015

Sierra Oncology, Inc. Reports